Louisville, Ky.-based Norton Heart & Vascular Institute performed Kentucky’s first transcatheter tricuspid valve replacement using the Evoque system.
The catheter-based procedure, developed by Edwards Lifesciences, treats severe tricuspid regurgitation and offers a less invasive alternative to open-heart surgery. The Evoque valve is the first transcatheter therapy approved by the FDA for this condition, according to a Dec. 11 Norton Healthcare news release.
The procedure reduces symptoms and improves recovery time. Two successful implantations were completed Dec. 9, according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
